Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Math Technique De-Clutters Cancer-Cell Data, Revealing Tumor Evolution, Treatment Leads

June 7, 2013 By Cold Spring Harbor Laboratory

In our daily lives, clutter is something that gets in our way, something that makes it harder for us to accomplish things. For doctors and scientists trying to parse mountains of raw biological data, clutter is more than a nuisance; it can stand in the way of figuring out how best to treat someone who is very sick.

Using increasingly cheap and rapid methods to read the billions of “letters” that comprise human genomes – including the genomes of individual cells sampled from cancerous tumors — scientists are generating far more data than they can easily interpret.

Today, two scientists from Cold Spring Harbor Laboratory (CSHL) publish a mathematical method of simplifying and interpreting genome data bearing evidence of mutations, such as those that characterize specific cancers. Not only is the technique highly accurate; it has immediate utility in efforts to parse tumor cells, in order to determine a patient’s prognosis and the best approach to treatment.

CSHL Assistant Professor Alexander Krasnitz, who developed the new technique jointly with American Cancer Society Professor Michael Wigler, explains that it reduces the burden of interpretation by identifying what he and Wigler call COREs, an acronym for “cores of recurrent events.”

Consider the example of a cancerous breast tumor. Central to the CORE concept is what Krasnitz and Wigler refer to as “intervals.” An example of an interval would be a segment of DNA that is missing in the genetic sequence of one or more cells sampled from the tumor. Tumor cells are often missing DNA that should normally be present; or conversely, they often have genome intervals in which the normal DNA sequence is amplified – it appears in multiple copies. Such deletions and amplifications are called copy-number variations, or CNVs.

“In cancer,” says Krasnitz, “we find intervals in the genome that are hit again and again. You might see this in many cells coming from a single patient’s tumor; or you may see these repeating patterns in cells sampled from many patients with a similar cancer type.”

In either case, if you superimpose the location of each “hit” – whether a deletion or an amplification of DNA — against a map of the full human genome, “you end up with these wobbly pile-ups, stacks of ‘hits’ at the same locations in the genome.”

Due to the vagaries of collecting genome data and a certain amount of small-scale variation in the precise boundaries of the deleted or amplified DNA intervals, the stacks don’t line up straight; as Krasnitz says, they look “wobbly.” This makes them very hard to accurately interpret.

The CORE method he and Wigler describe in a paper appearing in Proceedings of the National Academy of Sciences “is a mathematical way of cleaning up this mess and untangling these stacks of data, which often overlap.” When data from 100 cells from a single tumor are analyzed, for example, and the mathematical algorithm devised by Krasnitz and Wigler is applied, the regularity of the stacks is revealed, and the rich structure of the data emerges.

In the example of analyzing 100 cells from one tumor, the net result is that populations and subpopulations of cancer cells can be distinguished; and if the cancer has already become metastatic, CORE will be useful in discerning the relations among cancer cell subpopulations in various parts of the body. Such analysis is a potentially valuable guide to prognosis and can also help to make important treatment decisions.

For more information, visit Cold Spring Harbor Laboratory.

Related Articles Read More >

The most innovative medical devices of 2026
An illustration showing Corcym's Memo 4D Curve's laser-cut nitinol core.
Laser-cut nitinol and a layered design let these cardiac implants flex
Reconstructed 3D fluorescence image of the stained biohybrid mesh-tissue integration. The red, green, and blue colors correspond to the mesh, F-actin, and nuclei, respectively.
Researchers mesh electronics with human cells to develop living battery
A photo of the Paradromics Connexus brain-computer interface on a fingertip.
How Paradromics designed its Connexus brain-computer interface system
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2026 Arrowfly, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe